ACELYRIN, Inc. Class Action Lawsuit - SLRN

If you suffered losses in ACELYRIN stock, contact ACELYRIN stock loss lawyer Timothy L. Miles about an ACELYRIN class action lawsuit

Everything You Need to Know about the ACELYRIN Class Action Lawsuit

The ACELYRIN class action lawsuit seeks to represent purchasers or acquirers of ACELYRIN, Inc. (NASDAQ: SLRN) securities between May 4, 2023 and September 11, 2023 (the “Class Period”). Captioned Aramouni v. ACELYRIN, Inc., No. 23-cv-09672 (C.D. Cal.), the ACELYRIN class action lawsuit charges ACELYRIN and certain of its top current and former executive officers with violations of the Securities Exchange Act of 1934.

If you suffered losses in ACELYRIN stock and wish to serve as lead plaintiff in the ACELYRIN class action lawsuit, please contact ACELYRIN Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the ACELYRIN class action lawsuit must be filed with the court no later than January 16, 2024.

Allegations in the ACELYRIN Class Action Lawsuit

ACELYRIN is a clinical biopharma company that focuses on developing and commercializing transformative medicines. According to the ACELYRIN class action lawsuit, ACELYRIN’s lead product candidate is izokibep, which is currently in Part B of a Phase 2b/3 clinical trial for use in the treatment of moderate to severe Hidradenitis Suppurativa (“HS”).

The ACELYRIN class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) izokibep was less effective in treating HS than defendants had led investors to believe; (ii) accordingly, ACELYRIN overstated izokibep’s clinical and/or commercial prospects; and (iii) as a result, ACELYRIN also overstated its business prospects post-initial public offering.

The ACELYRIN class action lawsuit further alleges that on September 11, 2023, ACELYRIN announced disappointing top-line results from Part B of the Phase 2b/3 trial evaluating izokibep for the treatment of moderate-to-severe HS. Specifically, izokibep failed to show statistically significant reduction in abscesses and inflammatory nodules in patients as compared to placebo, the complaint alleges. The ACELYRIN class action lawsuit alleges that on this news, the price of ACELYRIN stock fell more than 61% over two trading sessions.

WHAT IS THE LEAD PLAINTIFF DEADLINE IN THE ACELYRIN CLASS ACTION LAWSUIT?

When a securities class action is filed such as the ACELYRIN class action lawsuit, the person who files the first complaint is required to publish a notice announcing the filing. Anyone who wants to be lead plaintiff on behalf of the class in the ACELYRIN class action lawsuit must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published.

WHAT ARE MY CHOICES IF I RECEIVE A NOTICE IN THE ACELYRIN CLASS ACTION LAWSUIT?

First, read the notice very carefully. You have two choices. First, you can do nothing and remain a member of the class represented by lead counsel. Second, if you believe you have a large enough loss to justify it, you can opt out of the ACELYRIN class action lawsuit and file your own separate lawsuit. Note, that if you opt-out, you will not be able to participate in any settlement or recovery obtained in the ACELYRIN class action lawsuit.

IF I RECEIVE A SETTLEMENT FROM FINRA CAN I STILL PARTICIPATE IN THE ACELYRIN LAWSUIT?

Yes, the acceptance of restitution or compensation from a FINRA regulatory settlement does not waive your right to monetary or other benefits through the courts, arbitration, or mediation. Therefore, even if you received a settlement from FINRA, you can still participate in the ACELYRIN lawsuit.

what is the lead plaintiff process in the ACELYRIN class action lawsuit?

If you suffered losses in ACELYRIN stock, call an ACELYRIN Stock Loss Lawyer about an ACELYRIN class action lawsuit

The Private Securities Litigation Reform Act of 1995 permits any investor who purchased and suffered losses in ACELYRIN stock to seek appointment as lead plaintiff in the ACELYRIN class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.

A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the securities class action lawsuit. An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. If you suffered losses in ACELYRIN stock and have further questions, contact ACELYRIN stock loss Lawyer Timothy L. Miles today who will fight to recover your damages in a ACELYRIN class action lawsuit if you suffered losses in ACELYRIN stock.

CAN A NON-U.S. INVESTOR SERVE AS LEAD PLAINTIFF IN THE ACELYRIN CLASS ACTION LAWSUIT IF THEY SUFFERED LOSSES IN ACELYRIN stock?

Yes, courts in the U.S. have consistently recognized that non-U.S. investors, many of whom have substantial holdings, are adequate lead plaintiffs and have the same right to move for lead plaintiffs as U.S. investors. Thus, if a non-U.S. investor suffered losses in ACELYRIN stock, they may move the Court to be appointed lead plaintiff in the ACELYRIN class action lawsuit.

If I Suffered Losses in ACELYRIN Stock, What Are the Benefits of Serving as Lead Plaintiff in the ACELYRIN Class Action lawsuit?

Serving as a Lead Plaintiff in the ACELYRIN class action lawsuit has several advantages and important benefits including:

A Lead Plaintiff is able to negotiate more competitive attorney fees and reduce other litigation costs by actively monitoring the class counsel.
Lead Plaintiff has the benefit of being able to manage the litigation primarily by overseeing and monitoring the progress of the action and the efforts of counsel, and being able to review and comment on important filings and other documents pertaining to the prosecution of the action.
There is no financial risk in serving as a Lead Plaintiff because Lead Counsel advances all costs and expenses incurred it the prosecution of the case and will be reimbursed only if there is a successful settlement or judgment recovery on behalf of the class.
Lead Plaintiff has the benefit involved and active in all negotiations relating to any settlement.
Lead Plaintiffs that continue owning the stock of the defendant will enjoy the long-term benefits from governance reform resulting from the litigation.

Thus, there are numerous benefits and other advantages to serving as lead plaintiff in a class action against ACELYRIN if you suffered losses in ACELYRIN stock.

WHAT RESPONSIBILITIES WILL THE LEAD PLAINTIFF HAVE IN THE ACELYRIN CLASS ACTION LAWSUIT?

A Lead Plaintiff owes a fiduciary duty to the class, and therefore, must act in the best interest of the class in the ACELYRIN class action Lawsuit. Some of the responsibilities of the Lead Plaintiff in the ACELYRIN class action Lawsuit include:

Selecting, monitoring, and overseeing Lead Counsel.
Reviewing and commenting on court filings on behalf of the class.
Discussing litigation strategies with the Lead Counsel.
Attending depositions (if necessary) and giving a deposition.
Attending hearings (if necessary).
Participating in mediation and the trial (if necessary).
Provide input on any decision concerning the settlement of the securities class action.

Can I Be Appointed Lead Plaintiff in the ACELYRIN Class Action Lawsuit if I Purchased Shares Outside of the Class Period?

No. Even if you suffered losses in ACELYRIN stock, if you purchased securities outside of the Class period, you will not be able to participate in the ACELYRIN class action lawsuit.

Will the Lead Plaintiffs Get More Money than Class Members if the ACELYRIN Class Action Lawsuit settles?

No, but they may be entitled to recover their reasonable expenses incurred with are directly related to representing the class in the ACELYRIN class action lawsuit. Under the Private Securities Litigation Reform Act of 1995, a Lead Plaintiff is only entitled to his or her pro rata share of any recovery and does not receive any additional money for serving as a representative party on behalf of the class. However, a court, in its discretion, may approve an award of “reasonable costs and expenses (including lost wages)” to a Lead Plaintiff that directly relates to the representation of the class in the ACELYRIN class action lawsuit on behalf of investors who suffered losses in ACELYRIN stock.

Can I Be Lead Plaintiff in the ACELYRIN class action lawsuit if I am Lead Plaintiff in Another Case?

Yes, unless you have been a lead plaintiff in more than five securities class actions during any three-year period which is expressly prohibited by the securities laws. Otherwise, if you suffered losses in ACELYRIN stock, you may move to be appointed lead plaintiff in the ACELYRIN class action Lawsuit.

Can the Court Appoint More than One Lead Plaintiff in the ACELYRIN Lawsuit?

Yes, at its discretion the Court may appoint a person, entity, or group of persons and/or entities as Lead Plaintiffs to oversee the ACELYRIN lawsuit.

How Was the Class Period Determined in the ACELYRIN lawsuit?

Light green stock chart with securities fraud over middle

In a securities fraud class action, the class period refers to a period of time in which it is alleged the price of the company’s stock was artificially inflated due to false and misleading statements made by company executives. The class period starts when the company makes an untrue statement of material fact about the company or fails to disclose a material fact necessary to render other statements not misleading. The class period ends when the truth is revealed to the investing public through a corrective disclosure.

In order to be a part of the class in the ACELYRIN lawsuit, you must have suffered losses in ACELYRIN stock by purchasing during the class period when it is alleged the price of the stock was artificially inflated to be included in the class action against ACELYRIN.

CAN I SELL MY STOCK AND STILL BE A MEMBER OF THE CLASS IN THE ACELYRIN CLASS ACTION LAWSUIT?

Yes. There is no requirement for you to retain ownership of the stock after the class period has expired to participate in the ACELYRIN class action lawsuit.

How Can an ACELYRIN Stock Loss Lawyer Help Me if I Suffered Losses in ACELYRIN Stock?

An ACELYRIN stock loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation and focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, they have lost money due to mistakes, incompetence, or fraud by an investment professional.

While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discover every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct. Look for a securities lawyer with experience, high ethical standards, verifiable credentials, and a trustworthy reputation among his peers and the judiciary, as well as testimonials from previous clients and awards and recognitions.

Call an ACELYRIN stock loss Lawyer today if you suffered losses in ACELYRIN stock about the ACELYRIN class action lawsuit who will fight to recover your suffered losses in ACELYRIN stock.

How Do I Know if I am a Member of the Class in the ACELYRIN Class Action Lawsuit?

If you purchased shares during the class period and suffered losses in ACELYRIN stock, then you are most likely a member of the class in the ACELYRIN class action lawsuit and may participate in the ACELYRIN class action lawsuit since you suffered losses in ACELYRIN stock.